fr | en
Micro et Nanomédecines translationnelles

3 PhDs fellows are joining MINT


Etienne Chèvremont is an engineer in Chemical and Materials Sciences from University of Liège, Belgium. His Ph.D. thesis is a collaboration between Le Mans university and Angers university on  "Formulation of Lipid nanocapsules (nanovectors for health) on microfluidic chips, in operando study of formulation pathways and their interactions with biomembranes." with Dr. Jean-Christophe Gimel (MINT) and Prof. Guillaume Brotons (IMMM/ Le Mans University).



Léa Daoud obtained her master’s degree in Material Chemistry from the University of Montpellier, where she conducted her master's research at the Institut Charles Gérard de Montpellier. During her internship, she specialized in the synthesis of Polyoxazoline to create thermoresponsive hydrogels, materials with unique properties. Presently, Léa is undertaking her Ph.D. at the MiNT Laboratory, under the supervision of Dr. Oksana KRUPKA. Her doctoral research centers on the synthesis of smart materials based on polyoxazoline for targeted drug delivery systems. This demonstrates a nuanced exploration into the intersection of chemistry and biomedical applications. Léa's academic journey underscores a commitment to advancing knowledge in materials science and contributing to the evolving landscape of drug delivery methodologies.




Fatma BOUELHASSAN obtained her Master's degree in Innovative Drugs from the Université de Bourgogne and conducted her thesis research at Universität Bonn, Germany. Her thesis focused on investigating the anti-inflammatory properties of a novel nanoformulation designed for the intra-articular administration of Adalimumab in rheumatoid arthritis. Presently, she is pursuing her Ph.D. at the MiNT Laboratory under the supervision of Dr. Emilie Roger. Her research involves developing a drug delivery system for the oral administration of peptides, which encompasses various stages, including identifying the appropriate nanoformulation, conducting physiochemical analysis, and characterizing the biopharmaceutical aspects of the system.